✦ LIBER ✦

Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis

✍ Scribed by Maxime Dougados, Alan Moore, Shaohua Yu, Xavier Gitton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P325 SUSTAINED PATIENT ACCEPTABLE SYMPTO

✍ M. Dougados; A. Moore; X. Gitton 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Celecoxib improves the efficiency of the

✍ C. Detrembleur; J. De Nayer; A. van den Hecke 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A double blind, randomized, placebo cont

✍ Shahram SADREDDINI; Hamid NOSHAD; Mahshid MOLAEEFARD; Ramona MOLOUDI; Mohamad-Re 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 322 KB

A multicentre, placebo-controlled, doubl

✍ Arvanitis, L.; Miller, B.; Fennimore, J. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A 2-year randomised, double-blind, place

✍ Hellio le Graverand, M.-P.; Clemmer, R. S.; Redifer, P.; Brunell, R. M.; Hayes, 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 352 KB

Efficacy and safety of leuprorelin in pa

✍ Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Yu Takeuchi; Motoshi Kawashima 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 232 KB